Figure 1.
Protective effect of SFN on H2O2-treated HUVECs. (A-C) HUVECs were treated with 200 µmol H2O2, with or without 1.0 µmol/l SFN pretreatment. (A) Cell viability of HUVECs was detected using CellTiter-Blue® assay. (B) Apoptosis was measured by flow cytometry. (C) Intracellular ROS levels were measured using the DCFH-DA probe. *P<0.05 vs. Control and #P<0.05 vs. H2O2. Data are presented as the mean ± standard deviation, n=5. SFN, sulforaphane; HUVECs, human umbilical vein endothelial cells; ROS, reactive oxygen species; DCFH-DA, 2',7'-dichlorofluorescin diacetate.